In vivo modeling of diffuse large B cell lymphoma (DLBCL) with the myeloid differentiation primary response gene 88 (MYD88) L265P mutation

被引：1
|
作者：
Ngo, Vu N. [1 ]
机构：
[1] Beckman Res Inst City Hope, Gehr Family Ctr Leukemia Res, Div Hematopoiet Stem Cell & Leukemia Res, Duarte, CA 91010 USA
来源：
TRANSLATIONAL CANCER RESEARCH | 2016年 / 5卷
关键词：
SOMATIC MUTATION; EXPRESSION; GENOME;
D O I：
10.21037/tcr.2016.10.38
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S852 / S854
页数：3
相关论文
共 50 条
  • [1] Clinicopathologic Significance of MYD88 L265P Mutation in Diffuse Large B-Cell Lymphoma (DLBCL)
    Talaat, Ahmed
    El-Ashwah, Shaimaa
    Tharwat, Layla
    Eladl, Ahmed
    Shamaa, Sameh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S430 - S430
  • [2] MYD88 expression and L265P mutation in diffuse large B-cell lymphoma
    Choi, Jung-Woo
    Kim, Younghye
    Lee, Ju-Han
    Kim, Young-Sik
    HUMAN PATHOLOGY, 2013, 44 (07) : 1375 - 1381
  • [3] Therapy for MYD88 L265P DLBCL
    Vermaat, Joost S. P.
    de Groen, Ruben A. L.
    BLOOD, 2025, 145 (10) : 998 - 1000
  • [4] DETECTION OF MYD88 L265P IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Sidorova, A.
    Zvonkov, E.
    Sudarikov, A.
    Severina, N.
    Gabeeva, N.
    Kovrigina, A.
    Troitskaya, V.
    Savchenko, V.
    HAEMATOLOGICA, 2015, 100 : 763 - 764
  • [5] CLINICAL IMPLICATIONS OF MYD88 L265P MUTATION IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Sidorova, A.
    Zvonkov, E.
    Sudarikov, A.
    Severina, N.
    Gabeeva, N.
    Kovrigina, A.
    Troitskaya, V.
    Savchenko, V.
    HAEMATOLOGICA, 2016, 101 : 816 - 816
  • [6] Lack of myeloid differentiation primary response protein MyD88 L265P mutation in primary cutaneous marginal zone lymphoma
    Brenner, I.
    Roth, S.
    Flossbach, L.
    Wobser, M.
    Rosenwald, A.
    Geissinger, E.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (06) : 1527 - 1528
  • [7] Expression of MYD88 L265P Mutation in Subtypes of Diffuse Large B-Cell Lymphoma in the Pakistani Population
    Shabir, Muhammad Hamad
    Din, Hafeez Ud
    Mahmood, Rafia
    Shehzad, Umair Aslam
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2025, 33 (01) : 10 - 14
  • [8] PREVALENCE OF MYD88 L265P MUTATION IN HISTOLOGICALLY PROVEN, DIFFUSE LARGE B-CELL VITREORETINAL LYMPHOMA
    Raja, Harish
    Salomao, Diva R.
    Viswanatha, David S.
    Pulido, Jose S.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (03): : 624 - 628
  • [9] Acquisition of MYD88 L265P mutation during treatment of diffuse large B cell lymphoma of the parotid gland
    Koto Fujiishi
    Riko Kitazawa
    Yusa Nagai
    Takafumi Watanabe
    Kenji Bando
    Shinji Kobayashi
    Yoshihiro Yakushijin
    Ryuma Haraguchi
    Sohei Kitazawa
    Virchows Archiv, 2014, 464 : 121 - 124
  • [10] MYD88 (L265P) MUTATION IS AN INDEPENDENT PROGNOSTIC FACTOR IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Fernandez, C.
    Garcia, M.
    Sanchez, B.
    Vela, M. C.
    Pairet, S.
    Camacho, L.
    Gimeno, E.
    Senin, A.
    Besses, C.
    Serrano, S.
    Salar, A.
    Bellosillo, B.
    HAEMATOLOGICA, 2014, 99 : 149 - 149
12345